Lineage Cell Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

SEC filing history

Showing 1-25 of 30 matching filings.

Per page
25
Current page
1
10-K/A File 001-12830

10-K/A filing

Filing date
27 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-K File 001-12830

10-K filing

Filing date
09 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-K File 001-12830

10-K filing

Filing date
10 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
10-K File 001-12830

10-K filing

Filing date
11 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
10-K/A File 001-12830

10-K/A filing

Filing date
28 Apr 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

10-K filing

Filing date
12 Mar 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
10-K/A File 001-12830

10-K/A filing

Filing date
01 May 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-12830

10-K/A filing

Filing date
30 Apr 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

10-K filing

Filing date
14 Mar 2019
Reporting date
31 Dec 2018
Next action
Verify source filing
10-K/A File 001-12830

10-K/A filing

Filing date
02 Apr 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

10-K filing

Filing date
15 Mar 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
10-K/A File 001-12830

BIOTIME, INC 10-K A 12-31-2016

Filing date
29 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

BIOTIME, INC 10-K 12-31-2016

Filing date
16 Mar 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
10-K/A File 001-12830

BIOTIME, INC. 10-KA 12-31-2015

Filing date
24 May 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

BIOTIME, INC 10-K 12-31-2015

Filing date
15 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
10-K/A File 001-12830

BIOTIME, INC 10K/A 12-31-2014

Filing date
29 Apr 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

BIOTIME, INC 10-K 12-31-2014

Filing date
11 Mar 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
10-K/A File 001-12830

BIOTIME, INC 10-KA 12-31-2013

Filing date
29 Apr 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

BIOTIME, INC 10-K 12-31-2013

Filing date
17 Mar 2014
Reporting date
31 Dec 2013
Next action
Verify source filing
10-K/A File 001-12830

BIOTIME, INC 10-KA 12-31-2012

Filing date
30 Apr 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12830

BIOTIME INC 10-K 12-31-2012

Filing date
18 Mar 2013
Reporting date
31 Dec 2012
Next action
Verify source filing
10-K/A File 001-12830

BIOTIME 10-K A 12-31-2011

Filing date
17 Sep 2012
Reporting date
31 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .